HRP-Linked Polyclonal Antibody to Retinoic Acid Receptor Alpha (RARa)
Cat# MBS2050130-0,2mL
Size : 0.2mL
Marca : MyBiosource
Retinoic Acid Receptor Alpha (RARa) Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Special Promotion Catalog #: MBS2050130SPECIAL PROMOTION: Get FREE Starbucks gift card (Maximum 5 gift cards/product). Gift card(s) will be included with shipment
MBS2050130 is an antibody targeting RARa. Also known as HRP-Linked Polyclonal Antibody to Retinoic Acid Receptor Alpha (RARa). Reactive in Human, Mouse, Rat, Pig. Host: Rabbit. More details
Product Overview
Online Datasheet in PDFProduct Name
Retinoic Acid Receptor Alpha (RARa), Polyclonal Antibody
Full Product Name
HRP-Linked Polyclonal Antibody to Retinoic Acid Receptor Alpha (RARa)
Product Gene Name
anti-RARa antibody
Product Synonym Names
RAR-A; NR1B1; RAR; RAR-Alpha; Nuclear Receptor Subfamily 1 Group B Member 1
Clonality
Polyclonal
Host
Rabbit
Species Reactivity
Human, Mouse, Rat, Pig
Concentration
500ug/ml (lot specific)
Matching Pairs
Unconjugated Antibody: RARa (MBS2032664)
HRP Conjugated Antibody: RARa (MBS2050130)
HRP Conjugated Antibody: RARa (MBS2050130)
Matching Pairs
HRP Conjugated Antibody: RARa (MBS2050130)
Immunogen: RARa (MBS2033293)
Immunogen: RARa (MBS2033293)
Molecular Weight
39,700 Da
OMIM
X06614 mRNA
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customer’s specifications, please inquire.
Immunogen
RARa (Ser68~Glu173)
Conjugation
HRP
Cross Reactivity
Human, Pig
Unconjugated Antibody
The unconjugated antibody version of this item is also available as catalog #MBS2032664
ISO Certification
Manufactured in an ISO 9001:2015 and ISO 13485:2016 Certified Laboratory.
Applications Tested/Suitable for anti-RARa antibody
Western Blot (WB), Immunocytochemistry (ICC), Immunohistochemistry (IHC) Formalin/Paraffin, ELISA (ELISA)
Other Notes
Small volumes of anti-RARa antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for RARa. It may not necessarily be applicable to this product.
NCBI Official Full Name
retinoic acid receptor alpha, partial
NCBI Official Synonym Full Names
retinoic acid receptor alpha
NCBI Official Symbol
RARA
NCBI Official Synonym Symbols
RAR; NR1B1
UniProt Protein Name
Retinoic acid receptor alpha
UniProt Synonym Protein Names
Nuclear receptor subfamily 1 group B member 1
Protein Family
Replication-associated recombination protein
UniProt Gene Name
RARA
UniProt Synonym Gene Names
NR1B1; RAR-alpha
NCBI Protein Information
retinoic acid receptor alpha
NCBI Summary for RARa
This gene represents a nuclear retinoic acid receptor. The encoded protein, retinoic acid receptor alpha, regulates transcription in a ligand-dependent manner. This gene has been implicated in regulation of development, differentiation, apoptosis, granulopoeisis, and transcription of clock genes. Translocations between this locus and several other loci have been associated with acute promyelocytic leukemia. Alternatively spliced transcript variants have been found for this locus.[provided by RefSeq, Sep 2010]
Show more UniProt Comments for RARa
RARA: is a receptor for retinoic acid, a potent mammalian morphogen and teratogen that has profound effects on vertebrate development. RARA is a member of the nuclear receptor superfamily. Controls cell function by directly regulating gene expression. Its phosphorylation is crucial for transcriptional activity. Aberrations involving RARA may be a cause of acute promyelocytic leukemia. Two splice-variant isoforms have been described.
Protein type: DNA-binding; Nuclear receptor; Oncoprotein; Transcription factor
Chromosomal Location of Human Ortholog: 17q21.2
Cellular Component: actin cytoskeleton; cell surface; cytoplasm; nuclear chromatin; nucleoplasm; nucleus
Molecular Function: alpha-actinin binding; chromatin DNA binding; enzyme binding; protein binding; protein domain specific binding; protein heterodimerization activity; protein kinase A binding; protein kinase B binding; receptor binding; retinoic acid binding; retinoic acid receptor activity; transcription coactivator activity; transcription corepressor activity; transcription factor activity; transcription factor binding
Biological Process: apoptotic cell clearance; negative regulation of granulocyte differentiation; negative regulation of interferon-gamma production; negative regulation of transcription, DNA-dependent; negative regulation of tumor necrosis factor production; positive regulation of binding; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of interleukin-13 production; positive regulation of interleukin-4 production; positive regulation of interleukin-5 production; positive regulation of T-helper 2 cell differentiation; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; protein amino acid phosphorylation; response to retinoic acid; retinoic acid receptor signaling pathway; signal transduction; transcription initiation from RNA polymerase II promoter
Disease: Acute Promyelocytic Leukemia
Show more Protein type: DNA-binding; Nuclear receptor; Oncoprotein; Transcription factor
Chromosomal Location of Human Ortholog: 17q21.2
Cellular Component: actin cytoskeleton; cell surface; cytoplasm; nuclear chromatin; nucleoplasm; nucleus
Molecular Function: alpha-actinin binding; chromatin DNA binding; enzyme binding; protein binding; protein domain specific binding; protein heterodimerization activity; protein kinase A binding; protein kinase B binding; receptor binding; retinoic acid binding; retinoic acid receptor activity; transcription coactivator activity; transcription corepressor activity; transcription factor activity; transcription factor binding
Biological Process: apoptotic cell clearance; negative regulation of granulocyte differentiation; negative regulation of interferon-gamma production; negative regulation of transcription, DNA-dependent; negative regulation of tumor necrosis factor production; positive regulation of binding; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of interleukin-13 production; positive regulation of interleukin-4 production; positive regulation of interleukin-5 production; positive regulation of T-helper 2 cell differentiation; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; protein amino acid phosphorylation; response to retinoic acid; retinoic acid receptor signaling pathway; signal transduction; transcription initiation from RNA polymerase II promoter
Disease: Acute Promyelocytic Leukemia
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-RARa antibody
| Reference Product | PubMed Publications |
|---|---|
| PML antibody | >467 publications with RARa and PML |
| RXRG antibody | >2 publications with RARa and RXRG |
| MED1 antibody | >2 publications with RARa and MED1 |
| NCOA3 antibody | >1 publications with RARa and NCOA3 |
Pathways associated with anti-RARa antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Activation Of HOX Genes During Differentiation Pathway antibodies | Activation Of HOX Genes During Differentiation Pathway Diagram |
| Activation Of Anterior HOX Genes In Hindbrain Development During Early Embryogenesis Pathway antibodies | Activation Of Anterior HOX Genes In Hindbrain Development During Early Embryogenesis Pathway Diagram |
| Acute Myeloid Leukemia Pathway antibodies | Acute Myeloid Leukemia Pathway Diagram |
| Acute Myeloid Leukemia Pathway antibodies | Acute Myeloid Leukemia Pathway Diagram |
| Adipogenesis Pathway antibodies | Adipogenesis Pathway Diagram |
| Developmental Biology Pathway antibodies | Developmental Biology Pathway Diagram |
| Gene Expression Pathway antibodies | Gene Expression Pathway Diagram |
| Generic Transcription Pathway antibodies | Generic Transcription Pathway Diagram |
| IL-3 Signaling Pathway antibodies | IL-3 Signaling Pathway Diagram |
| Integrated Pancreatic Cancer Pathway antibodies | Integrated Pancreatic Cancer Pathway Diagram |
Diseases associated with anti-RARa antibody
| Disease Name | Pubmed Publications |
|---|---|
| Leukemia, Promyelocytic, Acute Antibodies | >427 publications with RARa and Leukemia, Promyelocytic, Acute |
| Kidney Diseases Antibodies | >124 publications with RARa and Kidney Diseases |
| Proteinuria Antibodies | >80 publications with RARa and Proteinuria |
| Disease Models, Animal Antibodies | >44 publications with RARa and Disease Models, Animal |
| Breast Neoplasms Antibodies | >29 publications with RARa and Breast Neoplasms |
| Nervous System Diseases Antibodies | >17 publications with RARa and Nervous System Diseases |
| Neoplasms, Second Primary Antibodies | >11 publications with RARa and Neoplasms, Second Primary |
| Necrosis Antibodies | >9 publications with RARa and Necrosis |
| Cardiovascular Diseases Antibodies | >9 publications with RARa and Cardiovascular Diseases |
| Neoplasms, Experimental Antibodies | >9 publications with RARa and Neoplasms, Experimental |
Organs/Tissues associated with anti-RARa antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >239 publications with RARa and Blood |
| Kidney Antibodies | >195 publications with RARa and Kidney |
| Bone Antibodies | >159 publications with RARa and Bone |
| Bone Marrow Antibodies | >147 publications with RARa and Bone Marrow |
| Vascular Antibodies | >53 publications with RARa and Vascular |
| Liver Antibodies | >28 publications with RARa and Liver |
| Skin Antibodies | >27 publications with RARa and Skin |
| Embryonic Tissue Antibodies | >22 publications with RARa and Embryonic Tissue |
| Brain Antibodies | >22 publications with RARa and Brain |
| Lung Antibodies | >18 publications with RARa and Lung |


